Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Den nuværende pris på Moderna Inc på markedet er 1.343,57 kr. med en 24-timers handelsvolumen på 696,19M kr.. Aktivets markedsværdi er 536,39B kr., efter at have bevæget sig 0.65% i løbet af det seneste døgn.
Tokeniseret Moderna Inc handles til 1.340,87 kr. med en tokeniseret markedsværdi på 16,43M kr. og en 24-timers handelsvolumen på 182,15M kr.. Det tokeniserede aktiv har flyttet sig -8.01% i de seneste 24 timer.